Skip to main content

Want a detailed portfolio tracker?

Qualigen Therapeutics, Inc. Common Stock (QLGN) Profit Margin (2020 - 2022)

Qualigen Therapeutics, Inc. Common Stock (QLGN) profit margin from Jun 30, 2020 to Jun 30, 2022. The current Qualigen Therapeutics, Inc. Common Stock (QLGN) profit margin is -288.81%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Qualigen Therapeutics, Inc. Common Stock (QLGN)

YearProfit MarginChange
2021-316.81%
N/A

Comparison Qualigen Therapeutics, Inc. Common Stock (QLGN) profit margin with competitors

Qualigen Therapeutics, Inc. Common Stock (QLGN) profit margin is -288.81%.

TickerNameProfit MarginUpside
OMEROmeros Corporation871.00%-401.58%
PRTCPureTech Health plc American Depositary Shares793.00%-374.57%
ABEOAbeona Therapeutics Inc454.90%-257.51%
CHRSCoherus Biosciences Inc397.30%-237.56%
INVAInnoviva Inc119.90%-141.52%
ZVRAZevra Therapeutics Inc101.60%-135.18%
ABUSArbutus Biopharma Corp94.73%-132.80%
SAVACassava Sciences Inc.93.68%-132.44%
GLPGGalapagos NV86.83%-130.06%
CTNMContineum Therapeutics Inc - Class A83.13%-128.78%
BDTXBlack Diamond Therapeutics Inc80.77%-127.97%
NEUPNeuphoria Therapeutics Inc75.08%-126.00%
IPSCCentury Therapeutics Inc70.13%-124.28%
FULCFulcrum Therapeutics Inc69.26%-123.98%
CVACCureVac N.V.68.44%-123.70%
PRTAProthena Corporation plc64.05%-122.18%
HCWBHCW Biologics Inc63.16%-121.87%
QTTBQ32 Bio Inc61.90%-121.43%
AVIRAtea Pharmaceuticals Inc60.95%-121.10%
ASNDAscendis Pharma A/S57.30%-119.84%
PLXProtalix BioTherapeutics Inc54.27%-118.79%
AGENAgenus Inc52.20%-118.07%
CGENCompugen Ltd48.57%-116.82%
KRYSKrystal Biotech Inc48.07%-116.64%
RPRXRoyalty Pharma plc - Class A46.73%-116.18%
XOMAPXOMA Corp45.90%-115.89%
XOMAOXOMA Corp45.90%-115.89%
AUPHAurinia Pharmaceuticals Inc44.21%-115.31%
NXTCNextcure Inc43.49%-115.06%
CPRXCatalyst Pharmaceuticals Inc42.66%-114.77%
HALOHalozyme Therapeutics Inc39.83%-113.79%
ADMAAdma Biologics Inc39.59%-113.71%
XOMAXOMA Corp36.25%-112.55%
VRTXVertex Pharmaceuticals Inc34.53%-111.96%
EXELExelixis Inc34.46%-111.93%
SLNOSoleno Therapeutics Inc33.17%-111.49%
CRMDCorMedix Inc30.29%-110.49%
TNGXTango Therapeutics Inc29.52%-110.22%
ARGXArgen X SE28.20%-109.76%
CAICaris Life Sciences Inc - Class A27.98%-109.69%
JAZZJazz Pharmaceuticals plc27.42%-109.49%
SPROSpero Therapeutics Inc24.90%-108.62%
INCYIncyte Corp23.83%-108.25%
REGNRegeneron Pharmaceuticals Inc20.17%-106.98%
NAGENiagen Bioscience Inc20.07%-106.95%
ICCCImmucell Corp18.75%-106.49%
NERVMinerva Neurosciences Inc17.79%-106.16%
ALNYAlnylam Pharmaceuticals Inc16.99%-105.88%
ENVBEnveric Biosciences Inc16.64%-105.76%
TECHBio-Techne Corp16.39%-105.67%
HRMYHarmony Biosciences Holdings Inc15.08%-105.22%
ONCBeiGene Ltd15.02%-105.20%
RIGLRigel Pharmaceuticals14.71%-105.09%
BMRNBiomarin Pharmaceutical Inc13.77%-104.77%
VXRTVaxart Inc13.20%-104.57%
IMCRImmunocore Holdings plc12.16%-104.21%
VRNAVerona Pharma Plc11.56%-104.00%
SVASinovac Biotech Ltd11.25%-103.90%
FBIOFortress Biotech Inc10.80%-103.74%
TGTXTG Therapeutics Inc9.65%-103.34%
PHARPharming Group N.V.7.76%-102.69%
APLSApellis Pharmaceuticals Inc6.95%-102.41%
PTGXProtagonist Therapeutics Inc6.71%-102.32%
NUVBNuvation Bio Inc - Class A6.48%-102.24%
FBIOPFortress Biotech Inc6.40%-102.22%
GMABGenmab5.92%-102.05%
SRPTSarepta Therapeutics Inc2.98%-101.03%
BMEABiomea Fusion Inc2.37%-100.82%
ACADAcadia Pharmaceuticals Inc1.36%-100.47%
FENCFennec Pharmaceuticals Inc1.33%-100.46%
FOLDAmicus Therapeutics Inc0.91%-100.32%
HOTHHoth Therapeutics Inc0.17%-100.06%
BBLGBone Biologics Corp0.02%-100.01%